Biotron (BIT) Stock Statistics & Valuation Metrics

Biotron has a market cap or net worth of AU$5.57M. The enterprise value is AU$6.55.

Biotron has 2,785,205,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biotron ’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -49.02%.

The current PE Ratio of Biotron is ―. Biotron ’s PEG ratio is 0.04.

In the last 12 months, Biotron had revenue of 0.00 and earned -1.52M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -1.92M and capital expenditures 0.00, giving a free cash flow of -1.92M billion.

Biotron pays an annual dividend of ―, resulting in a dividend yield of ―

Biotron upcoming earnings date is Mar 4, 2027, TBA (Confirmed).

Biotron as a current ratio of 1.94, with Debt / Equity ratio of 0.00%

In the past 12 months, Biotron has paid -525.87K in taxes.

Biotron EV to EBITDA ratio is -2.42, with an EV/FCF ratio of -2.63.

Biotron has AU$1.64M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.64M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Biotron is ―, which is 11.43% higher than the current price. The consensus rating is ―